Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 21, 2000

View Archived Issues

Medeva's Hepagene study shows promising results as treatment of chronic HBV

Periodontix raises funding for further development of HistaWash

Pharmacia & Upjohn and Geron extend telomerase collaboration

Therapeutic protein discovery partnership formed by Bayer and Incyte

Afferon steps up development of RTX for treatment of urge incontinence

Arena granted SBIR award for atypical antipsychotics

Neurocrine Biosciences updates clinical progress with IL-4 fusion toxin

SmithKline Beecham signs CpG DNA immune stimulant agreement

FDA approves two-dose regimen of Merck & Co.'s Recombivax HB for adolescent use

Positive results for memantine in phase IIb trial for treatment of neuropathy

Human Genome Sciences initiates phase II clinical trial of repifermin for mucositis

Synthesis, use of series of PDE4 inhibitors reported by Merck

Compounds active at human 5-HT1A receptors designed at AHP

Selective inhibitors of alpha4 integrin binding for inflammatory, immune disorders

Pfizer patents new series of COX-2 inhibitors with sulfonybenzene structure

Melanocortin receptor agonists and their use disclosed by Merck

Schering's new agents for eating disorders and diabetes presented in international patent

Novel amidino derivatives and their use as NOS inhibitors reported by Searle

Wide series of cell adhesion inhibitors in the Merck pipeline

German colorectal cancer patients have new treatment option: Sanofi-Synthelabo's Eloxatin

Enhancement of both upper and lower GI motility associated with selective 5-HT4 agonist

Ramipril and aminoguanidine both prevent albuminuria and normalize PKC in diabetic rats

Lipitor recommended for approval in Japan

RPR-120844: pharmacodynamic and antithrombotic profile of a new factor Xa inhibitor

Barr and DuPont to establish collaborative agreement

NAALADase inhibition as an effective and safe therapeutic strategy for stroke

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...